nodes	percent_of_prediction	percent_of_DWPC	metapath
Liothyronine—SLCO4C1—Methotrexate—urinary bladder cancer	0.184	0.245	CbGbCtD
Liothyronine—SLCO1C1—Methotrexate—urinary bladder cancer	0.129	0.172	CbGbCtD
Liothyronine—ABCB1—Mitomycin—urinary bladder cancer	0.0888	0.118	CbGbCtD
Liothyronine—SLCO1B3—Methotrexate—urinary bladder cancer	0.0723	0.0961	CbGbCtD
Liothyronine—SLCO1A2—Methotrexate—urinary bladder cancer	0.0446	0.0593	CbGbCtD
Liothyronine—SLCO1B1—Methotrexate—urinary bladder cancer	0.0421	0.056	CbGbCtD
Liothyronine—ALB—Fluorouracil—urinary bladder cancer	0.0418	0.0556	CbGbCtD
Liothyronine—SLC22A8—Methotrexate—urinary bladder cancer	0.0389	0.0517	CbGbCtD
Liothyronine—ABCB1—Gemcitabine—urinary bladder cancer	0.0256	0.034	CbGbCtD
Liothyronine—ALB—Methotrexate—urinary bladder cancer	0.0231	0.0306	CbGbCtD
Liothyronine—ABCB1—Cisplatin—urinary bladder cancer	0.0186	0.0247	CbGbCtD
Liothyronine—ABCB1—Etoposide—urinary bladder cancer	0.0182	0.0243	CbGbCtD
Liothyronine—ABCB1—Doxorubicin—urinary bladder cancer	0.0124	0.0165	CbGbCtD
Liothyronine—ABCB1—Methotrexate—urinary bladder cancer	0.0121	0.016	CbGbCtD
Liothyronine—TTR—urine—urinary bladder cancer	0.0104	0.0747	CbGeAlD
Liothyronine—SLC22A8—urine—urinary bladder cancer	0.00639	0.0458	CbGeAlD
Liothyronine—THRB—prostate gland—urinary bladder cancer	0.00503	0.0361	CbGeAlD
Liothyronine—THRA—prostate gland—urinary bladder cancer	0.00503	0.0361	CbGeAlD
Liothyronine—SLC10A1—prostate gland—urinary bladder cancer	0.00445	0.0319	CbGeAlD
Liothyronine—SLCO4C1—seminal vesicle—urinary bladder cancer	0.00444	0.0318	CbGeAlD
Liothyronine—SLC7A5—prostate gland—urinary bladder cancer	0.00384	0.0275	CbGeAlD
Liothyronine—SLC10A1—seminal vesicle—urinary bladder cancer	0.00376	0.027	CbGeAlD
Liothyronine—SLCO4C1—renal system—urinary bladder cancer	0.00358	0.0257	CbGeAlD
Liothyronine—THRA—renal system—urinary bladder cancer	0.00343	0.0246	CbGeAlD
Liothyronine—THRB—renal system—urinary bladder cancer	0.00343	0.0246	CbGeAlD
Liothyronine—SLCO4A1—prostate gland—urinary bladder cancer	0.00335	0.024	CbGeAlD
Liothyronine—SLC7A5—seminal vesicle—urinary bladder cancer	0.00325	0.0233	CbGeAlD
Liothyronine—Phlebitis—Carboplatin—urinary bladder cancer	0.00312	0.0972	CcSEcCtD
Liothyronine—SLC10A1—renal system—urinary bladder cancer	0.00303	0.0218	CbGeAlD
Liothyronine—SLC16A10—prostate gland—urinary bladder cancer	0.00294	0.0211	CbGeAlD
Liothyronine—SLCO1C1—renal system—urinary bladder cancer	0.00285	0.0205	CbGeAlD
Liothyronine—SLCO4A1—seminal vesicle—urinary bladder cancer	0.00284	0.0203	CbGeAlD
Liothyronine—SLC7A5—epithelium—urinary bladder cancer	0.00282	0.0202	CbGeAlD
Liothyronine—THRA—female reproductive system—urinary bladder cancer	0.00275	0.0197	CbGeAlD
Liothyronine—THRB—female reproductive system—urinary bladder cancer	0.00275	0.0197	CbGeAlD
Liothyronine—SLC7A5—smooth muscle tissue—urinary bladder cancer	0.00272	0.0195	CbGeAlD
Liothyronine—SLCO4C1—vagina—urinary bladder cancer	0.00259	0.0186	CbGeAlD
Liothyronine—SLC7A5—urethra—urinary bladder cancer	0.00257	0.0184	CbGeAlD
Liothyronine—TTR—renal system—urinary bladder cancer	0.00255	0.0183	CbGeAlD
Liothyronine—SLCO1B3—vagina—urinary bladder cancer	0.00252	0.0181	CbGeAlD
Liothyronine—THRB—vagina—urinary bladder cancer	0.00248	0.0178	CbGeAlD
Liothyronine—SLC10A1—female reproductive system—urinary bladder cancer	0.00243	0.0174	CbGeAlD
Liothyronine—SLC22A8—prostate gland—urinary bladder cancer	0.00229	0.0164	CbGeAlD
Liothyronine—SLCO4A1—renal system—urinary bladder cancer	0.00229	0.0164	CbGeAlD
Liothyronine—SLCO4A1—urethra—urinary bladder cancer	0.00225	0.0161	CbGeAlD
Liothyronine—Cardiac failure congestive—Mitomycin—urinary bladder cancer	0.00221	0.0687	CcSEcCtD
Liothyronine—SLC16A10—epithelium—urinary bladder cancer	0.00216	0.0155	CbGeAlD
Liothyronine—SLC7A5—female reproductive system—urinary bladder cancer	0.0021	0.015	CbGeAlD
Liothyronine—TTR—female reproductive system—urinary bladder cancer	0.00204	0.0146	CbGeAlD
Liothyronine—SLCO1B1—renal system—urinary bladder cancer	0.00201	0.0144	CbGeAlD
Liothyronine—SLC7A5—vagina—urinary bladder cancer	0.0019	0.0136	CbGeAlD
Liothyronine—SLCO4A1—female reproductive system—urinary bladder cancer	0.00183	0.0131	CbGeAlD
Liothyronine—SLCO4A1—vagina—urinary bladder cancer	0.00166	0.0119	CbGeAlD
Liothyronine—SLCO1A2—renal system—urinary bladder cancer	0.00164	0.0117	CbGeAlD
Liothyronine—SLCO1B1—female reproductive system—urinary bladder cancer	0.00161	0.0116	CbGeAlD
Liothyronine—THRB—lymph node—urinary bladder cancer	0.00161	0.0115	CbGeAlD
Liothyronine—THRA—lymph node—urinary bladder cancer	0.00161	0.0115	CbGeAlD
Liothyronine—SLC16A10—female reproductive system—urinary bladder cancer	0.00161	0.0115	CbGeAlD
Liothyronine—SLC22A8—renal system—urinary bladder cancer	0.00156	0.0112	CbGeAlD
Liothyronine—SLC16A10—vagina—urinary bladder cancer	0.00145	0.0104	CbGeAlD
Liothyronine—SLCO1C1—lymph node—urinary bladder cancer	0.00134	0.00958	CbGeAlD
Liothyronine—SLC7A5—lymph node—urinary bladder cancer	0.00123	0.00879	CbGeAlD
Liothyronine—Body temperature increased—Valrubicin—urinary bladder cancer	0.00113	0.0351	CcSEcCtD
Liothyronine—SLCO4A1—lymph node—urinary bladder cancer	0.00107	0.00768	CbGeAlD
Liothyronine—Body temperature increased—Carboplatin—urinary bladder cancer	0.00105	0.0325	CcSEcCtD
Liothyronine—Hypertension—Mitomycin—urinary bladder cancer	0.00104	0.0324	CcSEcCtD
Liothyronine—SLC16A10—lymph node—urinary bladder cancer	0.000939	0.00673	CbGeAlD
Liothyronine—Cardiac failure congestive—Gemcitabine—urinary bladder cancer	0.000934	0.0291	CcSEcCtD
Liothyronine—Phlebitis—Cisplatin—urinary bladder cancer	0.000916	0.0285	CcSEcCtD
Liothyronine—Cardiac failure congestive—Cisplatin—urinary bladder cancer	0.00087	0.0271	CcSEcCtD
Liothyronine—Phlebitis—Etoposide—urinary bladder cancer	0.000839	0.0261	CcSEcCtD
Liothyronine—ABCB1—prostate gland—urinary bladder cancer	0.000804	0.00577	CbGeAlD
Liothyronine—Cardiac failure congestive—Etoposide—urinary bladder cancer	0.000797	0.0248	CcSEcCtD
Liothyronine—Body temperature increased—Mitomycin—urinary bladder cancer	0.000778	0.0242	CcSEcCtD
Liothyronine—ALB—lymph node—urinary bladder cancer	0.000762	0.00547	CbGeAlD
Liothyronine—Angina pectoris—Fluorouracil—urinary bladder cancer	0.000701	0.0218	CcSEcCtD
Liothyronine—ABCB1—seminal vesicle—urinary bladder cancer	0.00068	0.00488	CbGeAlD
Liothyronine—Acute coronary syndrome—Gemcitabine—urinary bladder cancer	0.000643	0.02	CcSEcCtD
Liothyronine—Myocardial infarction—Gemcitabine—urinary bladder cancer	0.00064	0.0199	CcSEcCtD
Liothyronine—Acute coronary syndrome—Fluorouracil—urinary bladder cancer	0.000633	0.0197	CcSEcCtD
Liothyronine—Myocardial infarction—Fluorouracil—urinary bladder cancer	0.000629	0.0196	CcSEcCtD
Liothyronine—Arrhythmia—Thiotepa—urinary bladder cancer	0.000622	0.0194	CcSEcCtD
Liothyronine—Acute coronary syndrome—Cisplatin—urinary bladder cancer	0.0006	0.0187	CcSEcCtD
Liothyronine—Myocardial infarction—Cisplatin—urinary bladder cancer	0.000596	0.0186	CcSEcCtD
Liothyronine—ABCB1—epithelium—urinary bladder cancer	0.000591	0.00424	CbGeAlD
Liothyronine—Acute coronary syndrome—Etoposide—urinary bladder cancer	0.000549	0.0171	CcSEcCtD
Liothyronine—ABCB1—renal system—urinary bladder cancer	0.000548	0.00393	CbGeAlD
Liothyronine—Myocardial infarction—Etoposide—urinary bladder cancer	0.000546	0.017	CcSEcCtD
Liothyronine—ABCB1—urethra—urinary bladder cancer	0.000539	0.00386	CbGeAlD
Liothyronine—Hypertension—Thiotepa—urinary bladder cancer	0.000523	0.0163	CcSEcCtD
Liothyronine—Arrhythmia—Gemcitabine—urinary bladder cancer	0.000523	0.0163	CcSEcCtD
Liothyronine—Arrhythmia—Fluorouracil—urinary bladder cancer	0.000515	0.016	CcSEcCtD
Liothyronine—Arrhythmia—Cisplatin—urinary bladder cancer	0.000488	0.0152	CcSEcCtD
Liothyronine—Tachycardia—Thiotepa—urinary bladder cancer	0.000483	0.015	CcSEcCtD
Liothyronine—Phlebitis—Epirubicin—urinary bladder cancer	0.000471	0.0146	CcSEcCtD
Liothyronine—Cardiac failure congestive—Epirubicin—urinary bladder cancer	0.000447	0.0139	CcSEcCtD
Liothyronine—Hypertension—Gemcitabine—urinary bladder cancer	0.00044	0.0137	CcSEcCtD
Liothyronine—ABCB1—female reproductive system—urinary bladder cancer	0.000439	0.00315	CbGeAlD
Liothyronine—Phlebitis—Doxorubicin—urinary bladder cancer	0.000435	0.0136	CcSEcCtD
Liothyronine—Cardiac failure congestive—Doxorubicin—urinary bladder cancer	0.000414	0.0129	CcSEcCtD
Liothyronine—Tachycardia—Fluorouracil—urinary bladder cancer	0.000399	0.0124	CcSEcCtD
Liothyronine—ABCB1—vagina—urinary bladder cancer	0.000397	0.00285	CbGeAlD
Liothyronine—Body temperature increased—Thiotepa—urinary bladder cancer	0.000391	0.0122	CcSEcCtD
Liothyronine—Hypotension—Gemcitabine—urinary bladder cancer	0.000389	0.0121	CcSEcCtD
Liothyronine—Hypotension—Fluorouracil—urinary bladder cancer	0.000382	0.0119	CcSEcCtD
Liothyronine—Tachycardia—Cisplatin—urinary bladder cancer	0.000379	0.0118	CcSEcCtD
Liothyronine—Hypertension—Etoposide—urinary bladder cancer	0.000376	0.0117	CcSEcCtD
Liothyronine—Hypotension—Cisplatin—urinary bladder cancer	0.000363	0.0113	CcSEcCtD
Liothyronine—Tachycardia—Etoposide—urinary bladder cancer	0.000347	0.0108	CcSEcCtD
Liothyronine—Angina pectoris—Epirubicin—urinary bladder cancer	0.000341	0.0106	CcSEcCtD
Liothyronine—Hypotension—Etoposide—urinary bladder cancer	0.000332	0.0103	CcSEcCtD
Liothyronine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000329	0.0102	CcSEcCtD
Liothyronine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000324	0.0101	CcSEcCtD
Liothyronine—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000316	0.00983	CcSEcCtD
Liothyronine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000307	0.00955	CcSEcCtD
Liothyronine—Body temperature increased—Etoposide—urinary bladder cancer	0.000281	0.00875	CcSEcCtD
Liothyronine—ABCB1—lymph node—urinary bladder cancer	0.000257	0.00184	CbGeAlD
Liothyronine—Arrhythmia—Epirubicin—urinary bladder cancer	0.000251	0.0078	CcSEcCtD
Liothyronine—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000232	0.00722	CcSEcCtD
Liothyronine—Hypertension—Epirubicin—urinary bladder cancer	0.000211	0.00656	CcSEcCtD
Liothyronine—Hypotension—Methotrexate—urinary bladder cancer	0.000199	0.00619	CcSEcCtD
Liothyronine—Hypertension—Doxorubicin—urinary bladder cancer	0.000195	0.00607	CcSEcCtD
Liothyronine—Tachycardia—Epirubicin—urinary bladder cancer	0.000194	0.00605	CcSEcCtD
Liothyronine—Hypotension—Epirubicin—urinary bladder cancer	0.000186	0.0058	CcSEcCtD
Liothyronine—Tachycardia—Doxorubicin—urinary bladder cancer	0.00018	0.0056	CcSEcCtD
Liothyronine—Hypotension—Doxorubicin—urinary bladder cancer	0.000172	0.00536	CcSEcCtD
Liothyronine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000168	0.00524	CcSEcCtD
Liothyronine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000158	0.0049	CcSEcCtD
Liothyronine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000146	0.00454	CcSEcCtD
Liothyronine—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	6.06e-05	0.000793	CbGpPWpGaD
Liothyronine—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	6e-05	0.000786	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—TSC1—urinary bladder cancer	5.89e-05	0.000771	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—SLC19A1—urinary bladder cancer	5.83e-05	0.000764	CbGpPWpGaD
Liothyronine—TTR—Disease—NCOR1—urinary bladder cancer	5.83e-05	0.000763	CbGpPWpGaD
Liothyronine—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	5.8e-05	0.00076	CbGpPWpGaD
Liothyronine—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	5.79e-05	0.000758	CbGpPWpGaD
Liothyronine—SLC16A10—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.69e-05	0.000745	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—PRSS3—urinary bladder cancer	5.69e-05	0.000745	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	5.63e-05	0.000738	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—JAG1—urinary bladder cancer	5.6e-05	0.000734	CbGpPWpGaD
Liothyronine—ALB—Folate Metabolism—TNF—urinary bladder cancer	5.55e-05	0.000728	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	5.53e-05	0.000724	CbGpPWpGaD
Liothyronine—TTR—Disease—ERCC2—urinary bladder cancer	5.48e-05	0.000718	CbGpPWpGaD
Liothyronine—SLC7A5—Hemostasis—KRAS—urinary bladder cancer	5.42e-05	0.00071	CbGpPWpGaD
Liothyronine—ALB—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	5.39e-05	0.000707	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.33e-05	0.000698	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.33e-05	0.000698	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—TYMP—urinary bladder cancer	5.32e-05	0.000696	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—RRM2—urinary bladder cancer	5.28e-05	0.000692	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—GSTP1—urinary bladder cancer	5.25e-05	0.000688	CbGpPWpGaD
Liothyronine—TTR—Disease—MTHFR—urinary bladder cancer	5.15e-05	0.000675	CbGpPWpGaD
Liothyronine—TTR—Disease—TERT—urinary bladder cancer	5.14e-05	0.000673	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.1e-05	0.000669	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.08e-05	0.000666	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	4.9e-05	0.000642	CbGpPWpGaD
Liothyronine—ALB—Folate Metabolism—TP53—urinary bladder cancer	4.9e-05	0.000642	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—HPGDS—urinary bladder cancer	4.89e-05	0.000641	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—ENO2—urinary bladder cancer	4.89e-05	0.000641	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—TYMS—urinary bladder cancer	4.88e-05	0.00064	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.86e-05	0.000637	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—NCOR1—urinary bladder cancer	4.83e-05	0.000632	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—GSTM1—urinary bladder cancer	4.83e-05	0.000632	CbGpPWpGaD
Liothyronine—SLC7A5—Hemostasis—TP53—urinary bladder cancer	4.82e-05	0.000631	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—NAT2—urinary bladder cancer	4.81e-05	0.00063	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—GSTT1—urinary bladder cancer	4.74e-05	0.000622	CbGpPWpGaD
Liothyronine—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	4.73e-05	0.000619	CbGpPWpGaD
Liothyronine—TTR—Disease—FGFR3—urinary bladder cancer	4.71e-05	0.000617	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.67e-05	0.000612	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—GPX1—urinary bladder cancer	4.62e-05	0.000605	CbGpPWpGaD
Liothyronine—SLC7A5—Hemostasis—HRAS—urinary bladder cancer	4.61e-05	0.000604	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.56e-05	0.000597	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—TYMP—urinary bladder cancer	4.55e-05	0.000596	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—S100B—urinary bladder cancer	4.54e-05	0.000595	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—ERCC2—urinary bladder cancer	4.54e-05	0.000594	CbGpPWpGaD
Liothyronine—ALB—Metabolism—GSTZ1—urinary bladder cancer	4.52e-05	0.000592	CbGpPWpGaD
Liothyronine—SLCO1B3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.44e-05	0.000582	CbGpPWpGaD
Liothyronine—ALB—Selenium Micronutrient Network—TNF—urinary bladder cancer	4.41e-05	0.000578	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.37e-05	0.000572	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	4.33e-05	0.000567	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	4.31e-05	0.000565	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	4.29e-05	0.000562	CbGpPWpGaD
Liothyronine—ALB—Metabolism—GSTO2—urinary bladder cancer	4.29e-05	0.000562	CbGpPWpGaD
Liothyronine—ALB—Metabolism—NAT1—urinary bladder cancer	4.29e-05	0.000562	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—MTHFR—urinary bladder cancer	4.26e-05	0.000559	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.22e-05	0.000552	CbGpPWpGaD
Liothyronine—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	4.21e-05	0.000552	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—RRM2—urinary bladder cancer	4.15e-05	0.000544	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—NAT2—urinary bladder cancer	4.11e-05	0.000539	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—NCOR1—urinary bladder cancer	4.08e-05	0.000535	CbGpPWpGaD
Liothyronine—TTR—Disease—CREBBP—urinary bladder cancer	4.01e-05	0.000526	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	3.96e-05	0.000519	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—NQO1—urinary bladder cancer	3.94e-05	0.000517	CbGpPWpGaD
Liothyronine—SLC22A8—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.93e-05	0.000515	CbGpPWpGaD
Liothyronine—ALB—Metabolism—UGT2B7—urinary bladder cancer	3.92e-05	0.000514	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—ENO2—urinary bladder cancer	3.84e-05	0.000504	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—HPGDS—urinary bladder cancer	3.84e-05	0.000504	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.83e-05	0.000501	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.82e-05	0.000501	CbGpPWpGaD
Liothyronine—ALB—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	3.77e-05	0.000494	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	3.76e-05	0.000493	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GSTO2—urinary bladder cancer	3.76e-05	0.000492	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—NAT1—urinary bladder cancer	3.76e-05	0.000492	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—GSTT1—urinary bladder cancer	3.73e-05	0.000488	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	3.72e-05	0.000487	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.67e-05	0.000481	CbGpPWpGaD
Liothyronine—ALB—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.64e-05	0.000477	CbGpPWpGaD
Liothyronine—TTR—Disease—RHOA—urinary bladder cancer	3.63e-05	0.000476	CbGpPWpGaD
Liothyronine—THRA—Gene Expression—MYC—urinary bladder cancer	3.6e-05	0.000472	CbGpPWpGaD
Liothyronine—THRB—Gene Expression—MYC—urinary bladder cancer	3.6e-05	0.000472	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—TERT—urinary bladder cancer	3.6e-05	0.000471	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—RRM2—urinary bladder cancer	3.55e-05	0.000465	CbGpPWpGaD
Liothyronine—ALB—Metabolism—CYP4B1—urinary bladder cancer	3.53e-05	0.000463	CbGpPWpGaD
Liothyronine—SLCO1A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.49e-05	0.000457	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—PPARG—urinary bladder cancer	3.46e-05	0.000453	CbGpPWpGaD
Liothyronine—ALB—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	3.46e-05	0.000453	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	3.43e-05	0.00045	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—IFNA2—urinary bladder cancer	3.36e-05	0.000441	CbGpPWpGaD
Liothyronine—TTR—Disease—ERBB2—urinary bladder cancer	3.36e-05	0.00044	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.34e-05	0.000437	CbGpPWpGaD
Liothyronine—ALB—Metabolism—SLC19A1—urinary bladder cancer	3.33e-05	0.000437	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—CREBBP—urinary bladder cancer	3.32e-05	0.000435	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—FGFR3—urinary bladder cancer	3.3e-05	0.000432	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—GSTP1—urinary bladder cancer	3.29e-05	0.000431	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—ENO2—urinary bladder cancer	3.29e-05	0.000431	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—HPGDS—urinary bladder cancer	3.29e-05	0.000431	CbGpPWpGaD
Liothyronine—TTR—Disease—PTGS2—urinary bladder cancer	3.28e-05	0.00043	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.27e-05	0.000428	CbGpPWpGaD
Liothyronine—ALB—Metabolism—PRSS3—urinary bladder cancer	3.25e-05	0.000426	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—ESR1—urinary bladder cancer	3.21e-05	0.00042	CbGpPWpGaD
Liothyronine—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.19e-05	0.000418	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—GSTT1—urinary bladder cancer	3.19e-05	0.000418	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.18e-05	0.000417	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	3.15e-05	0.000413	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.14e-05	0.000411	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—NQO1—urinary bladder cancer	3.1e-05	0.000406	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	3.09e-05	0.000405	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	3.08e-05	0.000404	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—TYMS—urinary bladder cancer	3.06e-05	0.000401	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—GSTM1—urinary bladder cancer	3.02e-05	0.000396	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—NCOR1—urinary bladder cancer	3.02e-05	0.000396	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.01e-05	0.000394	CbGpPWpGaD
Liothyronine—SLCO1B1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.98e-05	0.000391	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	2.92e-05	0.000383	CbGpPWpGaD
Liothyronine—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	2.9e-05	0.00038	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—GPX1—urinary bladder cancer	2.89e-05	0.000379	CbGpPWpGaD
Liothyronine—TTR—Disease—CDKN1A—urinary bladder cancer	2.87e-05	0.000376	CbGpPWpGaD
Liothyronine—TTR—Disease—PTEN—urinary bladder cancer	2.86e-05	0.000375	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PRSS3—urinary bladder cancer	2.85e-05	0.000373	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—ERCC2—urinary bladder cancer	2.84e-05	0.000372	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—CREBBP—urinary bladder cancer	2.81e-05	0.000368	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	2.78e-05	0.000365	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—IGF1—urinary bladder cancer	2.77e-05	0.000363	CbGpPWpGaD
Liothyronine—TTR—Disease—EP300—urinary bladder cancer	2.73e-05	0.000358	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—PTGS2—urinary bladder cancer	2.72e-05	0.000356	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	2.69e-05	0.000353	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	2.69e-05	0.000352	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—MTHFR—urinary bladder cancer	2.67e-05	0.00035	CbGpPWpGaD
Liothyronine—TTR—Disease—SRC—urinary bladder cancer	2.66e-05	0.000348	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—NQO1—urinary bladder cancer	2.65e-05	0.000347	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.62e-05	0.000343	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.6e-05	0.000341	CbGpPWpGaD
Liothyronine—ALB—Metabolism—TYMP—urinary bladder cancer	2.6e-05	0.00034	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—GSTP1—urinary bladder cancer	2.58e-05	0.000339	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.57e-05	0.000337	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	2.56e-05	0.000336	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—RHOA—urinary bladder cancer	2.54e-05	0.000333	CbGpPWpGaD
Liothyronine—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	2.53e-05	0.000332	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.5e-05	0.000328	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.49e-05	0.000327	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	2.49e-05	0.000326	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—TYMS—urinary bladder cancer	2.4e-05	0.000315	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—PLAU—urinary bladder cancer	2.39e-05	0.000313	CbGpPWpGaD
Liothyronine—TTR—Disease—MYC—urinary bladder cancer	2.38e-05	0.000312	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—GSTM1—urinary bladder cancer	2.37e-05	0.000311	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—NCOR1—urinary bladder cancer	2.37e-05	0.000311	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—PTEN—urinary bladder cancer	2.37e-05	0.000311	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—ERBB2—urinary bladder cancer	2.35e-05	0.000308	CbGpPWpGaD
Liothyronine—ALB—Metabolism—NAT2—urinary bladder cancer	2.35e-05	0.000308	CbGpPWpGaD
Liothyronine—TTR—Disease—EGFR—urinary bladder cancer	2.33e-05	0.000305	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—TYMP—urinary bladder cancer	2.28e-05	0.000298	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—GPX1—urinary bladder cancer	2.27e-05	0.000298	CbGpPWpGaD
Liothyronine—SLC10A1—Metabolism—EP300—urinary bladder cancer	2.26e-05	0.000296	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.24e-05	0.000294	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.23e-05	0.000293	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—ERCC2—urinary bladder cancer	2.23e-05	0.000292	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—CXCL8—urinary bladder cancer	2.23e-05	0.000292	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—GSTP1—urinary bladder cancer	2.21e-05	0.000289	CbGpPWpGaD
Liothyronine—TTR—Disease—KRAS—urinary bladder cancer	2.2e-05	0.000288	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.18e-05	0.000286	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—PPARG—urinary bladder cancer	2.17e-05	0.000284	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.14e-05	0.00028	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—IL2—urinary bladder cancer	2.13e-05	0.000279	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—MTHFR—urinary bladder cancer	2.1e-05	0.000275	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—CREBBP—urinary bladder cancer	2.08e-05	0.000273	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.08e-05	0.000273	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—CCND1—urinary bladder cancer	2.08e-05	0.000272	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.06e-05	0.00027	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—NAT2—urinary bladder cancer	2.06e-05	0.00027	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—TYMS—urinary bladder cancer	2.05e-05	0.000269	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—NCOR1—urinary bladder cancer	2.03e-05	0.000266	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—GSTM1—urinary bladder cancer	2.03e-05	0.000266	CbGpPWpGaD
Liothyronine—ALB—Metabolism—RRM2—urinary bladder cancer	2.03e-05	0.000266	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—MMP9—urinary bladder cancer	2.02e-05	0.000264	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—CDKN1A—urinary bladder cancer	2.01e-05	0.000263	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—PTEN—urinary bladder cancer	2.01e-05	0.000263	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—CREBBP—urinary bladder cancer	1.97e-05	0.000258	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—IGF1—urinary bladder cancer	1.95e-05	0.000255	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—GPX1—urinary bladder cancer	1.94e-05	0.000255	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—EP300—urinary bladder cancer	1.91e-05	0.000251	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—ERCC2—urinary bladder cancer	1.91e-05	0.00025	CbGpPWpGaD
Liothyronine—ALB—Metabolism—HPGDS—urinary bladder cancer	1.88e-05	0.000246	CbGpPWpGaD
Liothyronine—ALB—Metabolism—ENO2—urinary bladder cancer	1.88e-05	0.000246	CbGpPWpGaD
Liothyronine—TTR—Disease—HRAS—urinary bladder cancer	1.87e-05	0.000245	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.87e-05	0.000245	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—SRC—urinary bladder cancer	1.86e-05	0.000244	CbGpPWpGaD
Liothyronine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.83e-05	0.00024	CbGpPWpGaD
Liothyronine—ALB—Metabolism—GSTT1—urinary bladder cancer	1.82e-05	0.000239	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—MTHFR—urinary bladder cancer	1.79e-05	0.000235	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.79e-05	0.000235	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—RHOA—urinary bladder cancer	1.78e-05	0.000233	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.78e-05	0.000233	CbGpPWpGaD
Liothyronine—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.7e-05	0.000223	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—PTGS2—urinary bladder cancer	1.7e-05	0.000223	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	1.7e-05	0.000223	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—MYC—urinary bladder cancer	1.67e-05	0.000218	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.65e-05	0.000216	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.65e-05	0.000216	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	1.63e-05	0.000214	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—EGFR—urinary bladder cancer	1.63e-05	0.000214	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.6e-05	0.000209	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—KRAS—urinary bladder cancer	1.54e-05	0.000202	CbGpPWpGaD
Liothyronine—ALB—Metabolism—NQO1—urinary bladder cancer	1.51e-05	0.000198	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—IL2—urinary bladder cancer	1.49e-05	0.000196	CbGpPWpGaD
Liothyronine—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.49e-05	0.000196	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—PTEN—urinary bladder cancer	1.49e-05	0.000195	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.47e-05	0.000192	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—PPARG—urinary bladder cancer	1.45e-05	0.000191	CbGpPWpGaD
Liothyronine—SLCO1B3—Metabolism—EP300—urinary bladder cancer	1.42e-05	0.000186	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—CREBBP—urinary bladder cancer	1.4e-05	0.000183	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—TP53—urinary bladder cancer	1.37e-05	0.000179	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—EP300—urinary bladder cancer	1.34e-05	0.000176	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	1.34e-05	0.000175	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.33e-05	0.000174	CbGpPWpGaD
Liothyronine—TTR—Signaling Pathways—HRAS—urinary bladder cancer	1.31e-05	0.000172	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—SRC—urinary bladder cancer	1.3e-05	0.000171	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.28e-05	0.000168	CbGpPWpGaD
Liothyronine—ALB—Metabolism—GSTP1—urinary bladder cancer	1.26e-05	0.000165	CbGpPWpGaD
Liothyronine—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.22e-05	0.00016	CbGpPWpGaD
Liothyronine—ALB—Metabolism—TYMS—urinary bladder cancer	1.17e-05	0.000154	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	1.17e-05	0.000153	CbGpPWpGaD
Liothyronine—ALB—Metabolism—NCOR1—urinary bladder cancer	1.16e-05	0.000152	CbGpPWpGaD
Liothyronine—ALB—Metabolism—GSTM1—urinary bladder cancer	1.16e-05	0.000152	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—PTGS2—urinary bladder cancer	1.14e-05	0.00015	CbGpPWpGaD
Liothyronine—SLCO1A2—Metabolism—EP300—urinary bladder cancer	1.11e-05	0.000146	CbGpPWpGaD
Liothyronine—ALB—Metabolism—GPX1—urinary bladder cancer	1.11e-05	0.000146	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.11e-05	0.000145	CbGpPWpGaD
Liothyronine—ALB—Metabolism—ERCC2—urinary bladder cancer	1.09e-05	0.000143	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—KRAS—urinary bladder cancer	1.08e-05	0.000142	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.03e-05	0.000135	CbGpPWpGaD
Liothyronine—ALB—Metabolism—MTHFR—urinary bladder cancer	1.03e-05	0.000134	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.02e-05	0.000133	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.02e-05	0.000133	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—PTEN—urinary bladder cancer	9.98e-06	0.000131	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—GPX1—urinary bladder cancer	9.73e-06	0.000128	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—TP53—urinary bladder cancer	9.6e-06	0.000126	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—ERCC2—urinary bladder cancer	9.56e-06	0.000125	CbGpPWpGaD
Liothyronine—SLCO1B1—Metabolism—EP300—urinary bladder cancer	9.52e-06	0.000125	CbGpPWpGaD
Liothyronine—ALB—Hemostasis—HRAS—urinary bladder cancer	9.18e-06	0.00012	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—MTHFR—urinary bladder cancer	8.98e-06	0.000118	CbGpPWpGaD
Liothyronine—ALB—Metabolism—PPARG—urinary bladder cancer	8.31e-06	0.000109	CbGpPWpGaD
Liothyronine—ALB—Metabolism—CREBBP—urinary bladder cancer	7.99e-06	0.000105	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PPARG—urinary bladder cancer	7.28e-06	9.54e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	7e-06	9.17e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—PTGS2—urinary bladder cancer	6.54e-06	8.57e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	5.73e-06	7.51e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—PTEN—urinary bladder cancer	5.7e-06	7.47e-05	CbGpPWpGaD
Liothyronine—ALB—Metabolism—EP300—urinary bladder cancer	5.44e-06	7.13e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—PTEN—urinary bladder cancer	5e-06	6.55e-05	CbGpPWpGaD
Liothyronine—ABCB1—Metabolism—EP300—urinary bladder cancer	4.77e-06	6.24e-05	CbGpPWpGaD
